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Brief Clinical Reportsoperating on all patients diagnosed with ALCAwhile calling
into question the utility of this approach for patients with
asymptomatic ARCA.
For those who have no symptoms, an exercise stress test is
usually performed to demonstrate evidence of ischemia.
These data help guide clinical decision making regarding
whether to proceed with surgical intervention. As recom-
mended in the most recent Bethesda guidelines, physicians
also use postoperative exercise stress testing before allowing
a patient to return to exercise.5 Our concern is that ischemia
is intermittent in AAOCA. Our patient with ALCA clearly
had evidence of ischemia on one exercise test and a normal
result just 1 week later. Symptoms of ischemia were not re-
liable, because the patient was free of symptoms during both
tests. Our patient could by chance have had two normal test
results and never had his ALCA diagnosed, possibly until
a sudden catastrophic event occurred. Indeed, more accurate
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for both preoperative and postoperative decision making
should be questioned.
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1326-33.Primary thoracic cavity gastrointestinal stromal tumorJi-Wei Cheng, MSc,a Shao-Hua Lu, MD,b Song-Tao Xu, MD,a Hao Wang, MD,a Ying-Yong Hou, MD,
PhD,b Ru-Heng Zheng, MD,a and Yun-Shan Tan, MD,b Shanghai, ChinaGastrointestinal stromal tumors (GISTs) are mesenchymal
tumors that mostly arise in the gastrointestinal tract. Other
locations such as the omentum, the mesentery, and the ret-
roperitoneum have also been reported. Here we report
a rare case of primary thoracic cavity GIST. Although
this rare tumor may be difficult to distinguish clinically
from more common mass lesions of the thoracic cavity,
a correct diagnosis is necessary because treatment is spe-
cific for GIST.
CLINICAL SUMMARY
First Operation
A 62-year-old female patient was hospitalized with
a 6-month history of common cold symptoms in September
2007. Her medical record and family history were unremark-able. The x-ray film showed a dense shadow in the middle
and lower lobes of the right lung (Figure 1, A). Computed
tomographic scan of the chest revealed a huge heteroge-
neous mass in the right thoracic cavity, the mediastinum
and the heart were pushed to the left, and no mediastinal
lymphadenopathy was found (Figure 1, B). There were no
other abnormalities by physical examination or laboratory
testing.
The patient was then scheduled for surgery because of
suspected lung neoplasm. At thoracotomy, there was an
800-mL reactive benign pleural effusion. The tumor was at-
tached to the diaphragm through a 2-cm pedicle and invaded
the right lower lobe of the lung but did not involve the esoph-
agus or other mediastinal structures. After the adhesion had
been separated from the lung, it was resected en bloc with
a portion of the diaphragm.
The tumor was covered with a pseudocapsule except for
the site where the tumor was attached to the diaphragm
with a gray-white mass measuring 20 3 15 3 10 cm.
Microscopically, the tumor was predominantly composed
of spindle-shaped cells with a moderate degree of nuclear
pleomorphism. Immunohistochemical studies revealed the
tumor cells positive for alpha smooth muscle actin and
CD34, focally positive for desmin. Considering the origi-
nation, morphologic features, and immunohistochemistry
of the tumor, leiomyosarcoma was finally reported.rdiovascular Surgery c Volume 140, Number 2 e29
FIGURE 1. A, X-ray film showed dense shadow in the middle and lower lobe of the right lung. B, Computed tomographic scan depicting a huge hetero-
geneous mass measuring 14.2 cm anteroposteriorly, 13.2 cm transversely and 16.4 cm craniocaudally in the right thoracic cavity. C, Computed tomographic
findings. A large tumor (long arrow) of 5 cm in diameter involved diaphragm and diaphragmatic surface of the right lower lung. A small tumor (short arrow)
of 1 cm in diameter was in the lateral segment of the right lower lung. D, Gross findings of the resected tumor. The tumor was white in cut surface and had
a clear boundary with lung tissue, measuring 5 3 4 3 4 cm in size.
Brief Clinical ReportsThe tumor was completely resected. With no adjuvant
therapy, the patient was disease free for 17 months until
recurrent tumor was found in the right thoracic cavity during
a regular check-up by computed tomographic scan (Fig-
ure 1, C).Second Operation
On the basis of the first pathologic examination, the
surgeons decided to resect the recurrent tumor because leio-
myosarcoma is insensitive to chemotherapy. At thoracot-
omy there were two tumors in the right thoracic cavity:
one was 1 cm in diameter in the lateral segment of the right
lower lung, and the other was 5 cm in diameter involving the
diaphragm and diaphragmatic surface of the right lower
lung. Right lower lobe lobectomy was performed with
wedge resection of the lung together with the two tumors,
as well as diaphragmatic resection and reconstruction. Nei-
ther tumor involved the esophagus or other mediastinal
structures.
The 53 43 4-cm tumor was white in cut surface and had
a clear boundary with lung tissue (Figure 1, D). Microscop-
ically, the tumor had uniform spindle cells with a moderate
degree of nuclear pleomorphism (Figure 2, A). The mitotic
index was 19/50 in high power fields. Immunohistochemical
studies showed positive staining for CD117 (c-kit) ande30 The Journal of Thoracic and Cardiovascular SurgCD34 antigens, whereas S-100 and alpha smooth muscle
actin staining was negative (Figure 2, B). Genetic analyses
revealed loss of heterozygosity at codon 567–576 of exon
11 of the c-kit gene accompanied AAG GAA insertion (Fig-
ure 2,C).1 The present case was positive for CD117 and c-kit
mutations, suggesting that it is a true primary thoracic cavity
GIST with high-grade malignancy based on the international
consensus on GIST.2 The postoperative course was unevent-
ful. Imatinib mesylate was recommended for the patient. At
present, 8 months after the second operation, the patient is in
good health and recurrence free with imatinib therapy.DISCUSSION
GISTs are mesenchymal tumors arising mostly in the
gastrointestinal tract, with locations in the stomach
(50%–70%), the small bowel (20%–30%), and the esoph-
agus, colon, and rectum (5%–10%).3-5 Primary GISTs out-
side the gastrointestinal tract are very uncommon. To the
best of our knowledge, this is the first reported case of a pri-
mary thoracic cavity GIST.
In this case, the tumor was located in the right thoracic
cavity and was found not to be adherent to the esophagus
during the first operation. The clinical findings of most cases,
which suggest the presence of a soft tissue tumor originating
from thoracic cavity, led to a false initial diagnosis.ery c August 2010
FIGURE 2. A, Microscopically, the tumor had uniform spindle cells with a moderate degree of nuclear pleomorphism. B, Immunohistochemical studies
showed positive staining for CD117 (c-kit). C, Genetic analyses revealed loss of heterozygosity at codon (the arrow indicates the beginning mutation locus)
567–576 of exon 11 of the c-kit gene accompanied AAG GAA insertion.
Brief Clinical ReportsImmunohistochemistry with c-kit is a key tool for correct
diagnosis. It is therefore strongly recommended that for
unusual spindle cell tumors of the thoracic cavity, immunos-
taining for kit and CD34 and mutational analysis for kit genes
should be performed so as to institute appropriate treatment.References
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